
Sonnet BioTherapeutics Holdings Inc (NASDAQ: SONN) Is Up 1.35% – Is It Capable Of A Rally?
Sonnet BioTherapeutics Holdings Inc (NASDAQ:SONN) traded at $9.77 at close of the session on Tuesday, July 15 and made an upward move of 1.35% on its previous day’s price. Looking at the stock we see that its previous close was $9.64 and the beta (5Y